Leland Gershell
Stock Analyst at Oppenheimer
Total Price Targets
23
Stocks Covered
15
Sectors
Healthcare
Most Recent
Dec 23, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Leland Gershell
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. Common Stock | $35.00 | $5.43 | +544.6% | 1 | Dec 23, 2025 |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $20.00 | $5.82 | +243.6% | 1 | Dec 10, 2025 |
| ENGN | enGene Holdings Inc. | $33.00 | $7.24 | +355.8% | 1 | Nov 12, 2025 |
| CPRX | Catalyst Pharmaceuticals, Inc. | $33.00 | $28.77 | +14.7% | 1 | Nov 7, 2025 |
| LGND | Ligand Pharmaceuticals Incorporated | $250.00 | $229.62 | +8.9% | 3 | Nov 3, 2025 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $500.00 | $297.62 | +68.0% | 1 | Oct 31, 2025 |
| XERS | Xeris Biopharma Holdings, Inc. | $18.00 | $6.26 | +187.5% | 2 | Oct 29, 2025 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $110.00 | $82.41 | +33.5% | 1 | Jul 10, 2025 |
| URGN | UroGen Pharma Ltd. | $31.00 | $23.37 | +32.6% | 4 | Jun 13, 2025 |
| DNTH | Dianthus Therapeutics, Inc. | $52.00 | $87.86 | -40.8% | 1 | Nov 11, 2024 |
| SLNO | Soleno Therapeutics, Inc. | $65.00 | $52.86 | +23.0% | 1 | Aug 27, 2024 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $74.00 | $38.93 | +90.1% | 3 | Jun 4, 2024 |
| IMVT | Immunovant, Inc. | $46.00 | $27.11 | +69.6% | 1 | Jun 3, 2024 |
| VRDN | Viridian Therapeutics, Inc. | $15.50 | $13.41 | +15.6% | 1 | May 9, 2024 |
| AVTX | Avalo Therapeutics, Inc. | $35.00 | $13.63 | +156.9% | 1 | Apr 16, 2024 |
Recent Activity
- Dec 23, 2025— Set$35.00price target onAARD(Aardvark Therapeutics, Inc. Common Stock)
- Dec 10, 2025— Set$20.00price target onLXEO(Lexeo Therapeutics, Inc. Common Stock)
- Nov 12, 2025— Set$33.00price target onENGN(enGene Holdings Inc.)
- Nov 7, 2025— Set$33.00price target onCPRX(Catalyst Pharmaceuticals, Inc.)
- Nov 3, 2025— Set$250.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Oct 31, 2025— Set$500.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Oct 29, 2025— Set$18.00price target onXERS(Xeris Biopharma Holdings, Inc.)
- Sep 3, 2025— Set$190.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Jul 10, 2025— Set$110.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
- Jun 13, 2025— Set$31.00price target onURGN(UroGen Pharma Ltd.)
- Nov 11, 2024— Set$52.00price target onDNTH(Dianthus Therapeutics, Inc.)
- Oct 23, 2024— Set$5.00price target onXERS(Xeris Biopharma Holdings, Inc.)
- Oct 2, 2024— Set$135.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Aug 27, 2024— Set$65.00price target onSLNO(Soleno Therapeutics, Inc.)
- Jun 14, 2024— Set$40.00price target onURGN(UroGen Pharma Ltd.)
- Jun 4, 2024— Set$74.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- Jun 3, 2024— Set$46.00price target onIMVT(Immunovant, Inc.)
- May 14, 2024— Set$32.00price target onURGN(UroGen Pharma Ltd.)
- May 9, 2024— Set$15.50price target onVRDN(Viridian Therapeutics, Inc.)
- Apr 16, 2024— Set$35.00price target onAVTX(Avalo Therapeutics, Inc.)
Frequently Asked Questions
Who is Leland Gershell?
Leland Gershell is a stock analyst at Oppenheimer covering 15 stocks primarily in Healthcare. They have issued 23 price targets since Aug 31, 2023.
What stocks does Leland Gershell cover?
Leland Gershell currently covers 15 stocks, including URGN, LGND, CRNX, XERS, AARD.
What is Leland Gershell's latest price target?
Leland Gershell's most recent price target was $35.00 on AARD (Aardvark Therapeutics, Inc. Common Stock), set on Dec 23, 2025.
What is Leland Gershell's highest price target?
Leland Gershell's highest issued price target is $500.00 on ALNY, set on Oct 31, 2025.
More Analysts at Oppenheimer
Coverage based on publicly published price targets. Not investment advice.